Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR17341
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Modi, S.; Gilham, D.; Sutclffe, M.; Lian, L.Y.; Primrose, W.; Wolf, C.; Roberts, G.. "1-Methyl-4-phenyl-1,2,3,6-tetrahydrophyridine as a Substrate of Cytochrome P450 2D6: Allosteric Effects of NADPH-Cytochrome P450 Reductase" Biochemistry 36, 4461-4470 (1997).
Assembly members:
CYP_2D6, polymer, 479 residues, Formula weight is not available
1-Methyl-4-phenyl-1,2,3,6-tetrahydrophyridine, non-polymer, 173.25 Da.
Natural source: Common Name: baculovirus Taxonomy ID: 10469 Superkingdom: virus Kingdom: not available Genus/species: not available not available
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET15b
Data type | Count |
binding constants | 1 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | CYP 2D6 | 1 |
2 | MPTP | 2 |
Entity 1, CYP 2D6 479 residues - Formula weight is not available
1 | MET | ALA | LYS | LYS | THR | SER | SER | LYS | GLY | LYS | ||||
2 | LEU | PRO | PRO | GLY | PRO | LEU | PRO | LEU | PRO | GLY | ||||
3 | LEU | GLY | ASN | LEU | LEU | HIS | VAL | ASP | PHE | GLN | ||||
4 | ASN | THR | PRO | TYR | CYS | PHE | ASP | GLN | LEU | ARG | ||||
5 | ARG | ARG | PHE | GLY | ASP | VAL | PHE | SER | LEU | GLN | ||||
6 | LEU | ALA | TRP | THR | PRO | VAL | VAL | VAL | LEU | ASN | ||||
7 | GLY | LEU | ALA | ALA | VAL | ARG | GLU | ALA | LEU | VAL | ||||
8 | THR | HIS | GLY | GLU | ASP | THR | ALA | ASP | ARG | PRO | ||||
9 | PRO | VAL | PRO | ILE | THR | GLN | ILE | LEU | GLY | PHE | ||||
10 | GLY | PRO | ARG | SER | GLN | GLY | VAL | PHE | LEU | ALA | ||||
11 | ARG | TYR | GLY | PRO | ALA | TRP | ARG | GLU | GLN | ARG | ||||
12 | ARG | PHE | SER | VAL | SER | THR | LEU | ARG | ASN | LEU | ||||
13 | GLY | LEU | GLY | LYS | LYS | SER | LEU | GLU | GLN | TRP | ||||
14 | VAL | THR | GLU | GLU | ALA | ALA | CYS | LEU | CYS | ALA | ||||
15 | ALA | PHE | ALA | ASN | HIS | SER | GLY | ARG | PRO | PHE | ||||
16 | ARG | PRO | ASN | GLY | LEU | LEU | ASP | LYS | ALA | VAL | ||||
17 | SER | ASN | VAL | ILE | ALA | SER | LEU | THR | CYS | GLY | ||||
18 | ARG | ARG | PHE | GLU | TYR | ASP | ASP | PRO | ARG | PHE | ||||
19 | LEU | ARG | LEU | LEU | ASP | LEU | ALA | GLN | GLU | GLY | ||||
20 | LEU | LYS | GLU | GLU | SER | GLY | PHE | LEU | ARG | GLU | ||||
21 | VAL | LEU | ASN | ALA | VAL | PRO | VAL | ASP | ARG | HIS | ||||
22 | ILE | PRO | ALA | LEU | ALA | GLY | LYS | VAL | LEU | ARG | ||||
23 | PHE | GLN | LYS | ALA | PHE | LEU | THR | GLN | LEU | ASP | ||||
24 | GLU | LEU | LEU | THR | GLU | HIS | ARG | MET | THR | TRP | ||||
25 | ASP | PRO | ALA | GLN | PRO | PRO | ARG | ASP | LEU | THR | ||||
26 | GLU | ALA | PHE | LEU | ALA | GLU | MET | GLU | LYS | ALA | ||||
27 | LYS | GLY | ASN | PRO | GLU | SER | SER | PHE | ASN | ASP | ||||
28 | GLU | ASN | LEU | ARG | ILE | VAL | VAL | ALA | ASP | LEU | ||||
29 | PHE | SER | ALA | GLY | MET | VAL | THR | THR | SER | THR | ||||
30 | THR | LEU | ALA | TRP | GLY | LEU | LEU | LEU | MET | ILE | ||||
31 | LEU | HIS | PRO | ASP | VAL | GLN | ARG | ARG | VAL | GLN | ||||
32 | GLN | GLU | ILE | ASP | ASP | VAL | ILE | GLY | GLN | VAL | ||||
33 | ARG | ARG | PRO | GLU | MET | GLY | ASP | GLN | ALA | HIS | ||||
34 | MET | PRO | TYR | THR | THR | ALA | VAL | ILE | HIS | GLU | ||||
35 | VAL | GLN | ARG | PHE | GLY | ASP | ILE | VAL | PRO | LEU | ||||
36 | GLY | MET | THR | HIS | MET | THR | SER | ARG | ASP | ILE | ||||
37 | GLU | VAL | GLN | GLY | PHE | ARG | ILE | PRO | LYS | GLY | ||||
38 | THR | THR | LEU | ILE | THR | ASN | LEU | SER | SER | VAL | ||||
39 | LEU | LYS | ASP | GLU | ALA | VAL | TRP | GLU | LYS | PRO | ||||
40 | PHE | ARG | PHE | HIS | PRO | GLU | HIS | PHE | LEU | ASP | ||||
41 | ALA | GLN | GLY | HIS | PHE | VAL | LYS | PRO | GLU | ALA | ||||
42 | PHE | LEU | PRO | PHE | SER | ALA | GLY | ARG | ARG | ALA | ||||
43 | CYS | LEU | GLY | GLU | PRO | LEU | ALA | ARG | MET | GLU | ||||
44 | LEU | PHE | LEU | PHE | PHE | THR | SER | LEU | LEU | GLN | ||||
45 | HIS | PHE | SER | PHE | SER | VAL | PRO | THR | GLY | GLN | ||||
46 | PRO | ARG | PRO | SER | HIS | HIS | GLY | VAL | PHE | ALA | ||||
47 | PHE | LEU | VAL | SER | PRO | SER | PRO | TYR | GLU | LEU | ||||
48 | CYS | ALA | VAL | PRO | ARG | HIS | HIS | HIS | HIS |
Entity 2, MPTP - C12 H15 N - 173.25 Da.
1 | MPTP |
sample_1: MPTP1 30 uM; CYP 2D61 30 mM; phosphate buffer 0.1 mM; H2O%
sample_conditions_1: pH: 8.0; pressure: 1 atm; temperature: 277 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
1H NMR | sample_1 | isotropic | sample_conditions_1 |
NMRCLUST, (Kelley et al., 1996) - conformational clustering
MODELLER, (Sali & Blundell, 1993) - structure solution
PDB | |
EMBL | CAA30807 |
GB | AAA36403 AAA52153 AAA53500 AAH75023 AAH75024 |
REF | NP_000097 NP_001035712 XP_005278411 XP_008975012 XP_011528268 |
SP | P10635 Q2XNC8 |
AlphaFold | P10635 Q2XNC8 |